Pennant Group Resultados de beneficios anteriores

Pasado controles de criterios 5/6

Pennant Group ha aumentado sus beneficios a una tasa media anual de 11.5%, mientras que los beneficios de la industria de Healthcare han experimentado un crecimiento de 5.4% anual. Los ingresos han ido creciendo a una tasa media de 11.9% al año. La rentabilidad financiera de Pennant Group es de 11.6%, y sus márgenes netos son de 3.2%.

Información clave

11.5%

Tasa de crecimiento de los beneficios

14.3%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare	8.5%
Tasa de crecimiento de los ingresos	11.9%
Rentabilidad financiera	11.6%
Margen neto	3.2%
Próxima actualización de resultados	06 Nov 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Is Now The Time To Put Pennant Group (NASDAQ:PNTG) On Your Watchlist?

Oct 06

Investors Still Waiting For A Pull Back In The Pennant Group, Inc. (NASDAQ:PNTG)

Sep 14

Investors Could Be Concerned With Pennant Group's (NASDAQ:PNTG) Returns On Capital

Dec 25

Pennant Group (NASDAQ:PNTG) Is Reinvesting At Lower Rates Of Return

Sep 02

Pennant acquires California-based Ardent Hospice and Palliative Care

Aug 16

Pennant Non-GAAP EPS of $0.14 in-line, revenue of $116.3M beats by $4.02M

Aug 08

Pennant Group (NASDAQ:PNTG) Takes On Some Risk With Its Use Of Debt

Jun 28

Desglose de ingresos y gastos

Cómo gana y gasta dinero Pennant Group. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

NasdaqGS:PNTG Ingresos, gastos y beneficios (USD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
30 Jun 24	612	19	92
31 Mar 24	575	16	88
31 Dec 23	545	13	84
30 Sep 23	524	13	81
30 Jun 23	502	13	77
31 Mar 23	486	7	77
31 Dec 22	473	7	78
30 Sep 22	460	1	80
30 Jun 22	454	-3	83
31 Mar 22	448	3	83
31 Dec 21	440	3	81
30 Sep 21	436	9	81
30 Jun 21	422	12	81
31 Mar 21	405	14	77
31 Dec 20	391	16	75
30 Sep 20	372	8	71
30 Jun 20	362	5	64
31 Mar 20	352	4	64
31 Dec 19	339	3	61
30 Sep 19	324	10	57
30 Jun 19	309	13	55
31 Mar 19	296	14	51
31 Dec 18	286	16	49
31 Dec 17	251	10	46
31 Dec 16	217	8	41

Ingresos de calidad: PNTG tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio (3.2%) de PNTG son superiores a los del año pasado (2.6%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de PNTG han crecido un 11.5% al año en los últimos 5 años.

Acelerando crecimiento: El crecimiento de los beneficios de PNTG en el último año (49.2%) supera su media de 5 años (11.5% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de PNTG en el último año (49.2%) superó al de la industria Healthcare 11.4%.

Pennant Group Resultados de beneficios anteriores

Pasado controles de criterios 5/6

Información clave

Actualizaciones de resultados anteriores recientes

The Pennant Group, Inc. to Report Q3, 2024 Results on Nov 06, 2024

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

The Pennant Group, Inc. to Report Q2, 2024 Results on Aug 06, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

The Pennant Group, Inc. to Report Q1, 2024 Results on May 06, 2024

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Recent updates

Price target increased by 12% to US$37.50

The Pennant Group, Inc. to Report Q3, 2024 Results on Nov 06, 2024

Price target increased by 9.5% to US$34.50

Is Now The Time To Put Pennant Group (NASDAQ:PNTG) On Your Watchlist?

The Pennant Group, Inc. has completed a Follow-on Equity Offering in the amount of $108.5 million.

New minor risk - Shareholder dilution

The Pennant Group, Inc. has completed a Follow-on Equity Offering in the amount of $108.5 million.

The Pennant Group, Inc. has filed a Follow-on Equity Offering.

The Pennant Group, Inc. has filed a Follow-on Equity Offering.

Now 21% undervalued

Price target increased by 12% to US$33.50

Investors Still Waiting For A Pull Back In The Pennant Group, Inc. (NASDAQ:PNTG)

Now 21% undervalued

Does Pennant Group (NASDAQ:PNTG) Have A Healthy Balance Sheet?

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 20% undervalued

The Pennant Group, Inc. Updates Earnings Guidance for the Year 2024

CEO & Director notifies of intention to sell stock

The Pennant Group, Inc. to Report Q2, 2024 Results on Aug 06, 2024

Price target increased by 7.8% to US$27.50

Independent Director exercised options to buy US$1.3m worth of stock.

The Pennant Group, Inc. acquired Nurses On Wheels, Inc.

Now 21% undervalued

Here's Why Pennant Group (NASDAQ:PNTG) Can Manage Its Debt Responsibly

Price target increased by 13% to US$24.75

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

The Pennant Group, Inc. (NasdaqGS : PNTG) acquired South Davis Community Hospital, Inc.

The Pennant Group, Inc. to Report Q1, 2024 Results on May 06, 2024

New minor risk - Shareholder dilution

The Pennant Group, Inc., Annual General Meeting, May 23, 2024

President & COO exercised options to buy US$214k worth of stock.

The Pennant Group, Inc. (NASDAQ:PNTG) Not Flying Under The Radar

Price target increased by 22% to US$19.50

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

The Pennant Group, Inc. Provides Revenue Guidance for 2024

The Pennant Group, Inc. to Report Q4, 2023 Results on Feb 28, 2024

Pennant Group (NASDAQ:PNTG) Takes On Some Risk With Its Use Of Debt

Price target increased by 10% to US$16.00

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

the Pennant Group, Inc. Provides Earnings Guidance for the Year 2023

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Guardian Hospice of Texas and Guardian Hospice of Oklahoma.

The Pennant Group, Inc. to Report Q3, 2023 Results on Nov 07, 2023

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Valor HospiceCare.

Price target decreased by 7.1% to US$14.25

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

The Pennant Group, Inc. to Report Q2, 2023 Results on Aug 08, 2023

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Bluebird Home Health, Bluebird Hospice, and Bluebird Home Care.

Price target decreased by 8.5% to US$15.33

The Pennant Group, Inc. Announces Jennifer Freeman Assume the Role of Senior Vice President of Strategic Partnerships

Investor sentiment deteriorates as stock falls 18%

The Pennant Group, Inc. acquired Assets Of Benefit Health Care.

The Returns On Capital At Pennant Group (NASDAQ:PNTG) Don't Inspire Confidence

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment improves as stock rises 16%

Independent Chairman recently bought US$67k worth of stock

Investor sentiment improves as stock rises 20%

Is Pennant Group (NASDAQ:PNTG) A Risky Investment?

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

The Pennant Group, Inc. to Report Q4, 2022 Results on Feb 23, 2023

Investors Could Be Concerned With Pennant Group's (NASDAQ:PNTG) Returns On Capital

Consensus forecasts updated

The Pennant Group, Inc. (NasdaqGS:PNTG) announces an Equity Buyback for $1 million worth of its shares.

Independent Director recently bought US$203k worth of stock

Consensus forecasts updated

Consensus forecasts updated

The Pennant Group, Inc. Announces Resignation of Derek Bunker,Chief Investment Officer, Executive Vice President and Corporate Secretary, Effective December 31, 2022

Price target decreased to US$15.40

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

The Pennant Group, Inc. Provides Earnings Guidance for the Year 2022